Results 21 to 30 of about 1,935,200 (187)

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. [PDF]

open access: yes, 2009
BACKGROUND: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI)
Brodie, Bruce R.   +23 more
core   +1 more source

An Analysis of Cost-Effectiveness of Stents Used in the Treatment of Coronary Artery Disease

open access: yesBalkan Medical Journal, 2019
Background: There is only limited information about the cost-effectiveness of drug-eluting stents compared with bare-metal stents in Turkey. Aims: To evaluate bare-metal and drug-eluting stents used in the treatment of coronary artery disease from the ...
Ferda Işıkçelik   +2 more
doaj   +1 more source

Methods and Materials for Drug Eluting Urinary Stents Design and Fabrication [PDF]

open access: yes, 2022
After urinary stenting, patients often suffer from mid- and long-term complications, such as infections, bacterial colonization, encrustations, or stent obstruction which are related to the design, materials and surface properties of the stent.
Irene, Carmagnola   +2 more
core   +1 more source

Drug Distribution and Stent Retention of Drug Eluting Stents [PDF]

open access: yes, 2008
In this paper the examinations of drug eluting coronary stents are shown, such as the morphology of the coatings before expansion, drug distribution, the methodology and the value of stent retention.
Dobránszky, János   +3 more
core   +1 more source

Outcomes of supraflex Sirolimus-eluting coronary stents

open access: yesCurrent Medical Issues, 2022
Background: The development of a sirolimus-eluting coronary stent (SES) was a big step forward in interventional cardiology. SES has been demonstrated in large, randomized clinical studies to reduce angiographic restenosis and target vessel ...
Vishal Virendra Singh   +2 more
doaj   +1 more source

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy [PDF]

open access: yes, 2021
Introduction: Cardiac allograft vasculopathy remains one of the most important factors leading to chronic cardiac allograft rejection. When revascularization is needed percutaneous coronary interventions are the method of choice.
Lekston, Andrzej   +19 more
core   +1 more source

Biodegradable Cable-Tie Rapamycin-eluting Stents

open access: yesScientific Reports, 2017
“Cable-tie” type biodegradable stents with drug-eluting nanofiber were developed to treat rabbit denuded arteries in this study. Biodegradable stents were fabricated using poly-L-lactide film following being cut and rolled into a cable-tie type stent ...
Cheng-Hung Lee   +11 more
doaj   +1 more source

Reestenose tardia associada à fratura de stent Cypher Reestenosis tardía asociada a fractura de stent Cypher Late restenosis related to Cypher stent fracture

open access: yesArquivos Brasileiros de Cardiologia, 2009
Os stents farmacológicos representam um importante avanço na terapêutica da doença aterosclerótica coronariana. Recentemente tem sido descrita a fratura de stents farmacológicos, associada à reestenose e trombose.
Michel Pereira Cadore   +3 more
doaj   +1 more source

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

open access: yesJournal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan   +3 more
doaj   +1 more source

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis

open access: yesSAGE Open Medicine, 2014
Background: Reports regarding the relationship between the length and diameter of implanted drug-eluting stents and clinical and angiographic outcomes in dialysis patients are limited.
Hiroshi Fujita   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy